ARCHIVES

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

This article is from The Cancer Letter archive.

Vol. 06 No. 08 | February 22, 1980

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Approves CCOP, Limited Recompetition Of Cooperative Group Program, New Control Efforts

October 30, 1981

Many Colorectal Cancer Survivors Do Not Receive Recommended Follow-up Care

September 26, 2008

Moddelmog Steps Down At Komen For the Cure

November 20, 2009

Hatch Committee Clears Bill Blocking OMB Micromanagement

August 15, 1986

In Brief: Susan Braun Named CEO, Komen Foundation; NCCF Research Fellowship Honors Norman

July 12, 1996

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

September 27, 2013